Windtree Therapeutics, Inc. (WINT)
0.012
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
Windtree Therapeutics SG&A Expense (Quarterly) : 1.855M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 10.86M |
| Curis, Inc. | 3.653M |
| LadRx Corp. | 0.6909M |
| Plus Therapeutics, Inc. | 3.443M |
| Enzon Pharmaceuticals, Inc. | 0.229M |